New Zealand markets open in 34 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
303.37-1.60 (-0.52%)
At close: 04:04PM EDT
303.37 0.00 (0.00%)
After hours: 04:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.59B
Enterprise value 22.25B
Trailing P/E 34.00
Forward P/E 33.22
PEG ratio (5-yr expected) 4.28
Price/sales (ttm)8.08
Price/book (mrq)9.71
Enterprise value/revenue 7.72
Enterprise value/EBITDA 24.92

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3-6.65%
S&P500 52-week change 3-3.35%
52-week high 3475.35
52-week low 3288.12
50-day moving average 3368.94
200-day moving average 3409.31

Share statistics

Avg vol (3-month) 3428.71k
Avg vol (10-day) 3507.52k
Shares outstanding 574.08M
Implied shares outstanding 6N/A
Float 873.64M
% held by insiders 10.62%
% held by institutions 195.86%
Shares short (28 Apr 2022) 4983.38k
Short ratio (28 Apr 2022) 42.2
Short % of float (28 Apr 2022) 41.73%
Short % of shares outstanding (28 Apr 2022) 41.33%
Shares short (prior month 30 Mar 2022) 41.2M

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.24%
Trailing annual dividend rate 30.70
Trailing annual dividend yield 30.23%
5-year average dividend yield 40.39
Payout ratio 47.80%
Dividend date 302 Aug 2022
Ex-dividend date 418 Jul 2022
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 23.76%
Operating margin (ttm)26.90%

Management effectiveness

Return on assets (ttm)16.05%
Return on equity (ttm)32.94%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)38.66
Quarterly revenue growth (yoy)7.40%
Gross profit (ttm)1.18B
EBITDA 897.8M
Net income avi to common (ttm)684.4M
Diluted EPS (ttm)8.97
Quarterly earnings growth (yoy)14.90%

Balance sheet

Total cash (mrq)667.7M
Total cash per share (mrq)9.01
Total debt (mrq)331.2M
Total debt/equity (mrq)14.24
Current ratio (mrq)2.89
Book value per share (mrq)31.39

Cash flow statement

Operating cash flow (ttm)646.5M
Levered free cash flow (ttm)254.66M